IQVIA HOLDINGS INC. Lease, Cost
IQVIA HOLDINGS INC. (IQV) reported Lease, Cost of $178.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-02-17
- IQVIA HOLDINGS INC. lease, cost for the quarter ending 2020-12-31 was $60.00M, a 20.00% increase year-over-year.
- IQVIA HOLDINGS INC. lease, cost for the quarter ending 2020-09-30 was $52.00M, a 8.33% increase year-over-year.
- IQVIA HOLDINGS INC. lease, cost for the quarter ending 2020-06-30 was $54.00M, a 14.89% increase year-over-year.
- IQVIA HOLDINGS INC. lease, cost for the quarter ending 2019-12-31 was $50.00M.
- IQVIA HOLDINGS INC. lease, cost for fiscal 2025 was $178.00M, a 1.14% increase from fiscal 2024.
- IQVIA HOLDINGS INC. lease, cost for fiscal 2024 was $176.00M, a 1.12% decline from fiscal 2023.
- IQVIA HOLDINGS INC. lease, cost for fiscal 2023 was $178.00M, a 2.73% decline from fiscal 2022.
- IQVIA HOLDINGS INC. lease, cost for fiscal 2022 was $183.00M, a 5.67% decline from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $178.00M 10-K · filed 2026-02-17 | |||
| 2024-12-31 | $176.00M 10-K · filed 2026-02-17 | |||
| 2023-12-31 | $178.00M 10-K · filed 2026-02-17 | |||
| 2022-12-31 | $183.00M 10-K · filed 2025-02-13 | |||
| 2021-12-31 | $194.00M 10-K · filed 2024-02-15 | |||
| 2020-12-31 | $60.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $112.00M derived: sum of 2 quarters · filed 2023-02-15 | $166.00M derived: sum of 3 quarters · filed 2023-02-15 | $215.00M 10-K · filed 2023-02-15 |
| 2020-09-30 | $52.00M 10-Q · filed 2020-10-22 | $106.00M derived: sum of 2 quarters · filed 2020-10-22 | $155.00M 10-Q · filed 2020-10-22 | |
| 2020-06-30 | $54.00M 10-Q · filed 2020-07-23 | $103.00M 10-Q · filed 2020-07-23 | ||
| 2019-12-31 | $50.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $98.00M derived: sum of 2 quarters · filed 2022-02-16 | $145.00M derived: sum of 3 quarters · filed 2022-02-16 | $193.00M 10-K · filed 2022-02-16 |
| 2019-09-30 | $48.00M 10-Q · filed 2020-10-22 | $95.00M derived: sum of 2 quarters · filed 2020-10-22 | $143.00M 10-Q · filed 2020-10-22 | |
| 2019-06-30 | $47.00M 10-Q · filed 2020-07-23 | $95.00M 10-Q · filed 2020-07-23 | ||
| 2019-03-31 | $48.00M 10-Q · filed 2019-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |